[关于CYP2D6*10多态性和对塔莫西芬的不良反应之间的关联研究]
1Department of Breast Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
概括
乳腺癌的塔莫西芬治疗受CYP2D6*10基因变异的影响. 患有CT和TT基因型的患者需要加强子宫内膜监测和潜在的药物调整,因为子宫内膜变厚的风险增加.
科学领域:
- 药物基因组学 药物基因组学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 塔莫西芬是激素受体阳性乳腺癌的关键内分泌疗法.
- CYP2D6基因多态,特别是CYP2D6*10,可以影响他莫西芬的新陈代谢和疗效.
- 了解CYP2D6*10对不良反应的影响对于个性化治疗至关重要.
研究的目的:
- 调查CYP2D6*10基因多态性和乳腺癌患者中与他莫西芬相关的不良反应之间的关联.
- 评估CYP2D6*10基因定型在指导乳腺癌内分泌治疗中的临床实用性.
主要方法:
- 研究了一组177名HR阳性,术后乳腺癌患者的队列,这些患者接受了他莫西芬治疗.
- 在两年内收集了临床病理学数据和不良反应.
- 进行了CYP2D6基因多态检测和生物信息分析 (eQTL,转录因子结合).
主要成果:
- 在基因型之间没有观察到肝损伤,脂肪肝,子宫纤维瘤或瘤复发的显著差异.
- 与CC基因型 (P<0.01) 相比,CT+TT基因型患者的子宫内膜加厚发生率显著更高 (P<0.01).
- 生物信息分析表明,CYP2D6*10会影响CYP2D6的表达和乳腺组织中塔莫西芬的敏感性.
结论:
- 在乳腺癌患者中,CYP2D6*10多态影响着他莫西芬的疗效和安全性.
- 强化子宫内膜监测和及时调整药物建议在CYP2D6CT和TT基因型的患者.
- CYP2D6*10 基因定型可以帮助个性化他莫西芬治疗和风险管理.
相关概念视频
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
52
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
52
01:19Pharmacovigilance
755
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
755
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
33
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
33
01:19Factors Affecting Drug Biotransformation: Biological
85
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
85
01:14Drug Metabolism: Phase II Reactions
3.5K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.5K
01:21Factors Affecting Drug Response: Overview
1.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.7K